| Trademark Snap Shot Amendment & Mail Processing Stylesheet (Table presents the data on Amendment & Mail Processing Complete) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 87283834 | FILING DATE | 12/29/2016 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | LEE, JEANIE H |
L.O. ASSIGNED | 105 |
PUB INFORMATION |
|||
| RUN DATE | 03/14/2018 | ||
| PUB DATE | N/A | ||
| STATUS | 680-APPROVED FOR PUBLICATION | ||
| STATUS DATE | 03/13/2018 | ||
| LITERAL MARK ELEMENT | GAMIFANT | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
| 1 (b) | YES | 1 (b) | NO | 1 (b) | NO |
| 44D | YES | 44D | NO | 44D | NO |
| 44E | NO | 44E | YES | 44E | YES |
| 66A | NO | 66A | NO | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | YES |
| LITERAL MARK ELEMENT | GAMIFANT |
| MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
| COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | NovImmune SA |
| ADDRESS | 14 ch. des Aulx, Plan-les-Ouates Geneva, 1228 |
| ENTITY | 99-société anonyme (sa) |
| CITIZENSHIP | Switzerland |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 001 |
| DESCRIPTION TEXT | Biochemicals, namely, polypeptides, superantigens, biomarkers and antibodies for medical and scientific research; cells, cell extracts and components of cells for medical and scientific research; diagnostic agents for medical and scientific research; diagnostic biomarker reagent for biomarker reagents for medical and scientific research; diagnostic test kits consisting primarily of biomarkers for medical and scientific research; biochemical test kits consisting of assays and reagents for medical and scientific research purposes |
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | Pharmaceutical and biological preparations to treat immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; pharmaceutical and biological preparations based on polypeptides, superantigens, biomarkers and antibodies to treat immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; Pharmaceutical and biological preparations and immunotherapies being medical preparations for stimulating the immune response, all for use in the diagnosis, prevention, management and treatment of immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; therapeutic and diagnostic agents, preparations and substances for medical purpose for use in therapies for immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; biochemical substance, polypeptides, antibodies, biomarkers and superantigens for use in diagnoses and therapies for immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; engineered cell therapies, namely engineered T cells, immune cells, and antibodies for medical purposes; diagnostic biomarker reagents for medical purposes; diagnostic test kits consisting primarily of biomarkers for medical purposes; biochemical test kits comprised of assays and reagents for medical, diagnostic and therapeutic purposes |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 001 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
FOREIGN INFORMATION |
|
| PRIORITY CLAIMED | SEC. 44(D) ON Switzerland |
| APPLICATION NO. | 65783/2016 |
| APPLICATION FILING DATE | 12/23/2016 |
| FOREIGN REG NO. | 699214 |
| FOREIGN REG DATE | 02/24/2017 |
| FOREIGN RNWL NUM | N/A |
| DATE OF FOREIGN RNWL | N/A |
| FOREIGN EXPIRATION | 12/23/2026 |
| FOREIGN RNWL EXPIRATION | N/A |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 03/13/2018 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | 017 |
| 03/13/2018 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 016 |
| 03/12/2018 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 015 |
| 03/12/2018 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 014 |
| 11/02/2017 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 013 |
| 11/02/2017 | GNRT | O | NON-FINAL ACTION E-MAILED | 012 |
| 11/02/2017 | CNRT | R | NON-FINAL ACTION WRITTEN | 011 |
| 10/12/2017 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 010 |
| 10/12/2017 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 009 |
| 10/10/2017 | ALIE | A | ASSIGNED TO LIE | 008 |
| 09/27/2017 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 007 |
| 03/27/2017 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 006 |
| 03/27/2017 | GNRT | F | NON-FINAL ACTION E-MAILED | 005 |
| 03/27/2017 | CNRT | R | NON-FINAL ACTION WRITTEN | 004 |
| 03/27/2017 | DOCK | D | ASSIGNED TO EXAMINER | 003 |
| 01/10/2017 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
| 01/02/2017 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | Janet L. Cullum |
| CORRESPONDENCE ADDRESS | JANET L. CULLUM COOLEY LLP 1299 PENNSYLVANIA AVE., NW SUITE 700 WASHINGTON, DC 20004 |
| DOMESTIC REPRESENTATIVE | Janet L. Cullum |